BC Innovations | Oct 27, 2016
Distillery Therapeutics


TECHNOLOGY: Gene profiling A panel of five microRNAs could be used for the differential diagnosis of subtypes of aggressive prostate cancer and to predict the risk of disease progression. Exon sequencing of serum samples from...
BC Innovations | Apr 2, 2009
Distillery Therapeutics

Indication: Inflammation

This week in therapeutics Indication Target/marker/pathway Summary Licensing status Publication and contact information Inflammation Inflammation MicroRNA-106a (miRNA-106a); early growth response 1 (EGR1); specificity protein 1 transcription factor (SP1); IL-10 Studies in cell culture suggest that...
Items per page:
1 - 2 of 2